Furthermore, in the TCGA-BLCA cohort, PPARG expression was a differentiating feature between patients’ samples in UMAP projections and to a lesser extent SMAD3 and KLF4 expression (Fig. 6b). This evidence concerns the gene SMAD3 and bladder transitional cell carcinoma.